招银国际-锦欣生殖-1951.HK-Impressive business rebound in 2023-240402 港美研究 2024-04-02 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-昭衍新药-6127.HK-Recovery could be not earlier than 1H24-240402 港美研究 2024-04-02 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-药明生物-2269.HK-Expand overseas capacity to mitigate risks-240328 港美研究 2024-03-28 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-药明康德-603259-Best effort to ensure business continuity-240320 公司调研 2024-03-21 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-药明康德-603259-Peptide business becoming a new growth driver-231101 公司调研 2023-11-02 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-泰格医药-300347-Business stabilizing from late September-231030 公司调研 2023-10-30 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-昭衍新药-6127.HK-New orders slightly recovered in 2Q23-230904 港美研究 2023-09-04 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-平安好医生-1833.HK-Business restructuring closes to the end-230828 港美研究 2023-08-29 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-泰格医药-300347-Healthy growth amid challenging environment-230828 公司调研 2023-08-29 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-药师帮-9885.HK-Digitalizing outside-of-hospital pharmaceutical circulation market in China-230825 港美研究 2023-08-28 Jill Wu，Benchen Huang 买入 47 页 查看
招银国际-药明康德-603259-Impressive margin improvement in 1H23-230802 公司调研 2023-08-02 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-平安好医生-1833.HK-1H23E preview: Expecting Strategy 2.0 to gain momentum in post-pandemic periods-2 港美研究 2023-07-13 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-医思健康-2138.HK-Recovering cross-border medical consumption in FY24-230626 港美研究 2023-06-26 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-药明生物-2269.HK-2023E growth outlook remains intact-230621 港美研究 2023-06-21 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-医思健康-2138.HK-Rebound of cross-border consumption to fuel growth in FY24-230505 港美研究 2023-05-05 Jill Wu，Benchen Huang 买入 6 页 查看
招银国际-昭衍新药-6127.HK-Maintaining strong growth momentum-230502 港美研究 2023-05-05 Jill Wu，Benchen Huang 买入 5 页 查看
招银国际-泰格医药-300347-Healthy non-COVID revenue growth in 1Q23-230427 公司调研 2023-04-27 Jill Wu，Benchen Huang 买入 5 页 查看
会员中心 
开通会员